ADRA1D and cardiovascular disorder: Moreover, QiShenYiQi, a traditional Chinese medicine for cardiovascular disease, has been found to alleviate renal damage through downregulating alpha-1D adrenergic receptors and upregulating salt-inducible kinase 1 in the mice model [64].